FDA approves first treatment for rare connective tissue disorder
Drug Discovery World
AUGUST 21, 2023
Ipsen’s Sohonos (palovarotene) has become the first drug approved for patients with fibrodysplasia ossificans progressiva (FOP) in the US, following the granting of a marketing authorisation by the Food and Drug Administration (FDA). The EU’s regulator chose not to recommend the drug in January 2023.
Let's personalize your content